Author Archive: Jeremy Parkinson
E Thoughts On Growth Stocks: Apple, Sherwin-Williams, Disney
Here are some growth stocks that have recent positive catalysts. All three companies are managed well, which drives their stocks to outperform over the long-term. They all have a tendency to grow earnings at above average rates, which drives the stock’s outperformance. The Lower-Priced iPhone SE Apple (AAPL) will expand its user base with the […]
Marc Faber: Gold Still Most Desirable Currency In Wake Of Brussels Attack
After several years of low gold prices, 2016 has brought a rebound, with the metal rising almost 20% since the first of the year, although recent price corrections have slowed gold’s advance. After the Brussels terrorist attacks last Tuesday, gold rose briefly, but then was undercut by a strong U.S. dollar rally. Investors are wondering […]
E Short Term Alpha, With Defined Risk And Return
TM editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence. Illustrating a trade I initiated on Monday March 28th, the trade is based on the study of price patterns. The risk and return are defined, and the duration I am targeting is 6-8 […]
Dow Jones Industrial Average Today Climbs 19 Points Ahead Of Yellen Speech
Monday’s trading session was just another sign that the U.S. Federal Reserve is holding the markets hostage with mixed messages on the timing of its next interest rate hike. Like a dog told to come from across the yard while its leash is tied to a tree, the Dow Jones Industrial Average didn’t go anywhere today as traders await a speech from […]
Scana – Chart Of The Day
The Chart of the Day belongs to SCANA Corp. (NYSE:SCG). I found the electric utility stock by using Barchart to sort today’s All Time High list first by the most frequent number of new highs in the last month then for technical buy signals of 80% or better. I always use the Flipchart feature to review the charts. Since the Trend […]
E Rocky Road: Overestimating The Fed’s Influence
Rocky Road is more than an ice cream flavor, as numerous potholes threaten the lateral stability of a seemingly-rangebound market at a relatively high level. The market’s staggering January decline and subsequent February rebound did indeed start running into trouble around the ‘Ides of March’; then shuffled without resolution to this very moment (off the […]
Same Shape, Different Day
Well, my friends, it’s getting a little challenging adding a lot of new color to a market whose most recent changes for the entire trading day were down a few hundredths of a percentage point on Thursday and up a few hundredths of a percentage point today. Two words: Bo. Ring. The entire market can be beautifully summed up with a single index […]
Barclays Says Sell Ensco, Atwood With Offshore Recovery A Way Off
Barclays downgraded offshore oil drillers Ensco (ESV) and Atwood Oceanics (ATW) to Underweight, the firm’s equivalent of a sell rating, from Equal Weight. Large oil companies probably won’t undertake more drilling projects until at least early 2018, the firm believes. WHAT’S NEW: Barclays analyst J. David Anderson now does not expect the offshore oil drilling […]
Negative Supply And Demand Factors For Bonds Are Just As Bad For Stocks
Last week the Treasury cut back the supply of the 4 week bills to $55 billion from $60 billion. Today they just announced another cut, to $45 billion. As a result of continuing massive demand for short government paper, the 4 week bill rate broke down from its range and closed at 18 basis points […]
E Alder Biopharmaceuticals Inc. Soars 50% On Positive Phase 2 Results
Shares of Alder Biopharmaceuticals Inc. (ALDR) were up almost 50% today after the company announced positive phase 2 results in patients with chronic migraines. More specifically the trial was looking to see how much migraine prevention can be done using the company’s drug ALD403. The ALD403 drug showed that it could work quickly in patients […]
